\ Scientific Presentations 2013
ASX Linkedin Twitter               

 

Scientific Presentations 2013

Presentation Title Conference Date
CALM study: a phase II study of intratumoral Coxsackievirus A21 in patients with stage IIIc and stage IV malignant melanoma 8th World Congress of Melanoma, Hamburg 17 – 20 July 2013.
Major synergy between Coxsackievirus A21 (CAVATAKTM) and radiotherapy or chemotherapy in bladder cancer cell lines, due to up-regulation viral receptors ICAM-1 & DAF The Seventh International Meeting on Replicating Oncolytic Virus Therapeutics, Quebec, Canada 15-18 June 2013.
Investigation of Potential Oncolytic Effects of Replication-Competent Coxsackievirus A21 (CVA21) in Combination with Chemotherapy on Various Lung Carcinomas The Seventh International Meeting on Replicating Oncolytic Virus Therapeutics, Quebec, Canada 15-18 June 2013.
Combinatory Effects of Docetaxel with the Naturally Occurring Oncolytic Virus Coxsackievirus A21 (CVA21) The Seventh International Meeting on Replicating Oncolytic Virus Therapeutics, Quebec, Canada 15-18 June 2013.
Coxsackievirus A21 (CVA21) Immune Cell Interactions and Oncolytic Activity in Leukaemia The Seventh International Meeting on Replicating Oncolytic Virus Therapeutics, Quebec, Canada 15-18 June 2013.
CALM study A Phase II study of intratumoural Coxsackievirus A21 in patients with stage IIIc and stage IV malignant melanoma American Society of Clinical Oncology, Chicago 31 May – 4 Jun, 2013.
Viralytics Limited
Suite 305, Level 3, 66 Hunter Street
Sydney NSW 2000 Australia
T: +61 (0)2 9988 4000 F: +61 (0)2 8068 6038

© Viralytics Limited 2018